Vertex Pharmaceuticals reported $2.02B in Gross Profit on Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US USD 134.08M 5.5M
Acorda Therapeutics ACOR:US USD 26.91M 4.41M
Agios Pharmaceuticals AGIO:US USD 3.9M 898K
Alnylam Pharmaceuticals ALNY:US USD 283.77M 60.58M
Amgen AMGN:US USD 5.09B 28M
Biogen BIIB:US USD 1.97B 65.9M
Biomarin Pharmaceutical BMRN:US USD 410.25M 21.19M
Bluebird Bio BLUE:US USD 71K 297K
Bristol Myers Squibb BMY:US USD 8.89B 21M
Gilead Sciences GILD:US USD 5.99B 346M
Insmed INSM:US USD 46.23M 8.03M
Intercept Pharmaceuticals ICPT:US USD 77.19M 27K
Johnson & Johnson JNJ:US USD 15.94B 56M
Merk MRK:US USD 10.47B 610M
Moderna Inc MRNA:US USD 3.17B 902M
Neurocrine Biosciences NBIX:US USD 404.3M 22.5M
Novartis NOVN:VX USD 9.16B 21M
Pfizer PFE:US USD 14.47B 2.08B
Ptc Therapeutics PTCT:US USD 156.52M 46.6M
Puma Biotechnology PBYI:US USD 48.84M 4.23M
Regeneron Pharmaceuticals REGN:US USD 2.87B 255.4M
Roche Holding ROG:VX 22.04B 696M
Sarepta Therapeutics SRPT:US USD 227.63M 37.31M
Seattle Genetics SGEN:US USD 419.94M 17.76M
Ultragenyx Pharmaceutical RARE:US USD 98.03M 15.96M
United Therapeutics UTHR:US USD 432.7M 46.1M
Vertex Pharmaceuticals VRTX:US USD 2.02B 25.5M
YTE INCY:US USD 872.94M 98.92M